Xlife Sciences AG Strengthens Global Presence with Strategic Expansion and NASDAQ Listing of VERAXA
Xlife Sciences AG has unveiled its 2024 Annual Report, highlighting strategic expansion, technological milestones, and a strengthened presence on international capital markets, positioning the company for future success in the healthcare sector.
3 minutes to read